RNS Number : 3242P
Mothercare PLC
08 February 2023
 

8 February 2023

Mothercare plc 

Director/PDMR shareholdings

Mothercare plc has been notified of the following share transactions on 7 February 2023:

 

 

Mark Newton-Jones, Non- Executive Director acquired an additional 604,789 Mothercare plc shares.

 

Further details of the notifications as required under Article 19 of the EU Market Abuse Regulation are set out below:

 

Mothercare plc (the "Company")
Transaction notification

 

1.

Details of the person discharging managerial responsibilities/persons closely associated

a)

Name

Mark Newton-Jones

2.

Reason for notification

a)

Position/Status

Non - Executive Director

b)

Initial notification/amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Mothercare PLC

b)

LEI

213800ZL6RPV9Z9GFO74

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument and identification code

Ordinary Shares of £0.01 each in the capital of Mothercare plc
ISIN: GB0009067447

b)

Nature of transaction

Acquisition of ordinary shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

9.9p per share

604,789

d)

Aggregated Information

n/a

e)

Date of transaction

07 February 2023

f)

Place of transaction

London Stock Exchange (XLON)

 

Accordingly, Mr Newton-Jones has increased his interest from 1,867,710 to shares to 2,472,499.

 

Media enquiries to:
MHP Communications                        Email: mothercare@mhpc.com
Simon Hockridge                                  Tel: 07709 496125
Tim Rowntree

                                               

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHTPMMTMTIMBJJ